BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 10680448)

  • 21. Liposomal amphotericin B for treatment of pulmonary aspergillosis in a heart transplant patient.
    Katz NM; Pierce PF; Anzeck RA; Visner MS; Canter HG; Foegh ML; Pearle DL; Tracy C; Rahman A
    J Heart Transplant; 1990; 9(1):14-7. PubMed ID: 2313415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Case report. Chronic necrotizing pulmonary aspergillosis in a non-neutropenic patient treated with liposomal amphotericin B.
    Filippou N; Papachristou K; Ilias I; Pefanis A; Papaleftheris E; Iliopoulos I
    Mycoses; 2000 Sep; 43(7-8):313-5. PubMed ID: 11036403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amphotericin B in the treatment of saprophytic forms of pulmonary aspergillosis.
    Hammerman KJ; Sarosi GA; Tosh FE
    Am Rev Respir Dis; 1974 Jan; 109(1):57-62. PubMed ID: 4809164
    [No Abstract]   [Full Text] [Related]  

  • 24. Pulmonary aspergillosis.
    Strutz GM; Rossi NP; Ehrenhaft JL
    J Thorac Cardiovasc Surg; 1972 Dec; 64(6):963-8. PubMed ID: 4564491
    [No Abstract]   [Full Text] [Related]  

  • 25. Nebulized liposomal amphotericin B and combined systemic antifungal therapy for the treatment of severe pulmonary aspergillosis after allogeneic hematopoietic stem cell transplant for a fatal mitochondrial disorder.
    Castagnola E; Moresco L; Cappelli B; Cuzzubbo D; Moroni C; Lanino E; Faraci M
    J Chemother; 2007 Jun; 19(3):339-42. PubMed ID: 17594932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of invasive pulmonary aspergillosis in neutropenic patients by additional bronchoscopic amphotericin B instillation.
    Winkler J; Müller U; Nenoff P; Seyfarth HJ; Vogtmann M; Borte G; Pönisch W; Kahn T; Wirtz H; Schauer J; Hoheisel G
    Respiration; 2007; 74(6):663-73. PubMed ID: 17622755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B.
    Ozsahin H; von Planta M; Müller I; Steinert HC; Nadal D; Lauener R; Tuchschmid P; Willi UV; Ozsahin M; Crompton NE; Seger RA
    Blood; 1998 Oct; 92(8):2719-24. PubMed ID: 9763555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Itraconazole for the treatment of pulmonary aspergillosis in heart transplant recipients.
    Nanas JN; Saroglou G; Anastasiou-Nana MI; Kostis EB; Petrochilou-Paschou VP; Kontoyannis DA; Stamatelopoulos SF; Moulopoulos SD
    Clin Transplant; 1998 Feb; 12(1):30-4. PubMed ID: 9541420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fungal pneumonia (Part 4): invasive pulmonary aspergillosis.
    Herbert PA; Bayer AS
    Chest; 1981 Aug; 80(2):220-5. PubMed ID: 6788456
    [No Abstract]   [Full Text] [Related]  

  • 30. [Case of chronic necrotizing pulmonary aspergillosis successfully treated with a combination of liposomal amphotericin B and itraconazole].
    Kiyokawa H; Nakashima R; Takafuji S; Suzuki Y; Ito A
    Nihon Kokyuki Gakkai Zasshi; 2008 Jun; 46(6):448-54. PubMed ID: 18592989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multidimensional volumetric imaging of pulmonary infiltrates for measuring therapeutic response to antifungal therapy in experimental invasive pulmonary aspergillosis.
    Petraitis V; Petraitiene R; Solomon J; Kelaher AM; Murray HA; Mya-San C; Bhandary AK; Sein T; Avila NA; Basevicius A; Bacher J; Walsh TJ
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1510-7. PubMed ID: 16569871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liposomal nystatin against experimental pulmonary aspergillosis in persistently neutropenic rabbits: efficacy, safety and non-compartmental pharmacokinetics.
    Groll AH; Gonzalez CE; Giri N; Kligys K; Love W; Peter J; Feuerstein E; Bacher J; Piscitelli SC; Walsh TJ
    J Antimicrob Chemother; 1999 Jan; 43(1):95-103. PubMed ID: 10381106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Invasive pulmonary aspergillosis associated with influenza virus].
    Alba D; Gomez-Cerezo J; Cobo J; Ripoll MM; Molina F; Vazquez JJ
    An Med Interna; 1996 Jan; 13(1):34-6. PubMed ID: 8679822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative analysis of amphotericin B lipid complex and liposomal amphotericin B kinetics of lung accumulation and fungal clearance in a murine model of acute invasive pulmonary aspergillosis.
    Lewis RE; Liao G; Hou J; Chamilos G; Prince RA; Kontoyiannis DP
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1253-8. PubMed ID: 17261624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative efficacies, toxicities, and tissue concentrations of amphotericin B lipid formulations in a murine pulmonary aspergillosis model.
    Olson JA; Adler-Moore JP; Schwartz J; Jensen GM; Proffitt RT
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2122-31. PubMed ID: 16723574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aspergillosis in four renal transplant recipients. Diagnosis and effective treatment with amphotericin B.
    Burton JR; Zachery JB; Bessin R; Rathbun HK; Greenough WB; Sterioff S; Wright JR; Slavin RE; Williams GM
    Ann Intern Med; 1972 Sep; 77(3):383-8. PubMed ID: 4559787
    [No Abstract]   [Full Text] [Related]  

  • 37. Efficacy of high loading doses of liposomal amphotericin B in the treatment of experimental invasive pulmonary aspergillosis.
    Gavaldà J; Martín T; López P; Gomis X; Ramírez JL; Rodríguez D; Len O; Puigfel Y; Ruiz I; Pahissa A
    Clin Microbiol Infect; 2005 Dec; 11(12):999-1004. PubMed ID: 16307554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of pulmonary aspergillosis with transparietal injections of amphotericin B (apropos of 3 cases)].
    Migueres J; Jover A; Krempf M
    Poumon Coeur; 1971; 27(9):947-58. PubMed ID: 5153635
    [No Abstract]   [Full Text] [Related]  

  • 39. Liposomal amphotericin B (AmBisome) reduces dissemination of infection as compared with amphotericin B deoxycholate (Fungizone) in a rate model of pulmonary aspergillosis.
    Leenders AC; de Marie S; ten Kate MT; Bakker-Woudenberg IA; Verbrugh HA
    J Antimicrob Chemother; 1996 Aug; 38(2):215-25. PubMed ID: 8877535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination amphotericin B-rifampin therapy for pulmonary aspergillosis in a leukemic patient.
    Ribner B; Keusch GT; Hanna BA; Perloff M
    Chest; 1976 Nov; 70(5):681-3. PubMed ID: 789031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.